Reported biochemical potency against human NNMT is in the low-micromolar range with cellular EC values in the low-micromolar range for suppression of 1-MNA and lipogenesis, with selectivity over related methyltransferases and NAD-salvage enzymes [1,6,7]
This is one of the primary risks associated with using experimental peptides from the grey market
Potential Side Effects and Precautions Known Adverse Reactions and Risk Factors Most users tolerate BPC 157 well, but reported side effects may include: Mild injection-site redness or irritation Occasional headache or nausea Possible blood-pressure changes, especially in people with hypertension Because high-quality human safety data are limited, users should monitor symptoms carefully and consult a healthcare professional if unusual effects appear
Side effects: Most patients have no significant side effects
But ultimate approval seems likely given Kennedys demonstrated enthusiasm for peptides
Typically, the type of dermal filler used to treat facial skin determines how long the results last